_version_ 1811079250017517568
author De Rycker, Manu
Horn, David
Aldridge, Bree
Amewu, Richard K.
Barry, Clifton E.
Buckner, Frederick S.
Cook, Sarah
Ferguson, Michael A. J.
Gobeau, Nathalie
Herrmann, Jennifer
Herrling, Paul
Hope, William
Keiser, Jennifer
Lafuente-Monasterio, Maria Jose
Leeson, Paul D.
Leroy, Didier
Manjunatha, Ujjini H.
McCarthy, James
Miles, Timothy J.
Mizrahi, Valerie
Moshynets, Olena
Niles, Jacquin
Overington, John P.
Pottage, John
Rao, Srinivasa P. S.
Read, Kevin D.
Ribeiro, Isabela
Silver, Lynn L.
Southern, Jen
Spangenberg, Thomas
Sundar, Shyam
Taylor, Caitlin
Van Voorhis, Wes
White, Nicholas J.
Wyllie, Susan
Wyatt, Paul G.
Gilbert, Ian H.
author2 Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
author_facet Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
De Rycker, Manu
Horn, David
Aldridge, Bree
Amewu, Richard K.
Barry, Clifton E.
Buckner, Frederick S.
Cook, Sarah
Ferguson, Michael A. J.
Gobeau, Nathalie
Herrmann, Jennifer
Herrling, Paul
Hope, William
Keiser, Jennifer
Lafuente-Monasterio, Maria Jose
Leeson, Paul D.
Leroy, Didier
Manjunatha, Ujjini H.
McCarthy, James
Miles, Timothy J.
Mizrahi, Valerie
Moshynets, Olena
Niles, Jacquin
Overington, John P.
Pottage, John
Rao, Srinivasa P. S.
Read, Kevin D.
Ribeiro, Isabela
Silver, Lynn L.
Southern, Jen
Spangenberg, Thomas
Sundar, Shyam
Taylor, Caitlin
Van Voorhis, Wes
White, Nicholas J.
Wyllie, Susan
Wyatt, Paul G.
Gilbert, Ian H.
author_sort De Rycker, Manu
collection MIT
description In May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings.
first_indexed 2024-09-23T11:12:13Z
format Article
id mit-1721.1/125959
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:12:13Z
publishDate 2020
publisher American Chemical Society (ACS)
record_format dspace
spelling mit-1721.1/1259592022-10-01T02:00:46Z Setting Our Sights on Infectious Diseases De Rycker, Manu Horn, David Aldridge, Bree Amewu, Richard K. Barry, Clifton E. Buckner, Frederick S. Cook, Sarah Ferguson, Michael A. J. Gobeau, Nathalie Herrmann, Jennifer Herrling, Paul Hope, William Keiser, Jennifer Lafuente-Monasterio, Maria Jose Leeson, Paul D. Leroy, Didier Manjunatha, Ujjini H. McCarthy, James Miles, Timothy J. Mizrahi, Valerie Moshynets, Olena Niles, Jacquin Overington, John P. Pottage, John Rao, Srinivasa P. S. Read, Kevin D. Ribeiro, Isabela Silver, Lynn L. Southern, Jen Spangenberg, Thomas Sundar, Shyam Taylor, Caitlin Van Voorhis, Wes White, Nicholas J. Wyllie, Susan Wyatt, Paul G. Gilbert, Ian H. Massachusetts Institute of Technology. Department of Civil and Environmental Engineering In May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings. 2020-06-23T20:18:16Z 2020-06-23T20:18:16Z 2019-12 2019-09 2020-03-12T18:19:37Z Article http://purl.org/eprint/type/JournalArticle 2373-8227 2373-8227 https://hdl.handle.net/1721.1/125959 De Rycker, Manu et al. "Setting Our Sights on Infectious Diseases." ACS Infectious Diseases 6, 1 (December 2019): 3–13 © 2019 American Chemical Society en http://dx.doi.org/10.1021/acsinfecdis.9b00371 ACS Infectious Diseases Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf American Chemical Society (ACS) ACS
spellingShingle De Rycker, Manu
Horn, David
Aldridge, Bree
Amewu, Richard K.
Barry, Clifton E.
Buckner, Frederick S.
Cook, Sarah
Ferguson, Michael A. J.
Gobeau, Nathalie
Herrmann, Jennifer
Herrling, Paul
Hope, William
Keiser, Jennifer
Lafuente-Monasterio, Maria Jose
Leeson, Paul D.
Leroy, Didier
Manjunatha, Ujjini H.
McCarthy, James
Miles, Timothy J.
Mizrahi, Valerie
Moshynets, Olena
Niles, Jacquin
Overington, John P.
Pottage, John
Rao, Srinivasa P. S.
Read, Kevin D.
Ribeiro, Isabela
Silver, Lynn L.
Southern, Jen
Spangenberg, Thomas
Sundar, Shyam
Taylor, Caitlin
Van Voorhis, Wes
White, Nicholas J.
Wyllie, Susan
Wyatt, Paul G.
Gilbert, Ian H.
Setting Our Sights on Infectious Diseases
title Setting Our Sights on Infectious Diseases
title_full Setting Our Sights on Infectious Diseases
title_fullStr Setting Our Sights on Infectious Diseases
title_full_unstemmed Setting Our Sights on Infectious Diseases
title_short Setting Our Sights on Infectious Diseases
title_sort setting our sights on infectious diseases
url https://hdl.handle.net/1721.1/125959
work_keys_str_mv AT deryckermanu settingoursightsoninfectiousdiseases
AT horndavid settingoursightsoninfectiousdiseases
AT aldridgebree settingoursightsoninfectiousdiseases
AT amewurichardk settingoursightsoninfectiousdiseases
AT barrycliftone settingoursightsoninfectiousdiseases
AT bucknerfredericks settingoursightsoninfectiousdiseases
AT cooksarah settingoursightsoninfectiousdiseases
AT fergusonmichaelaj settingoursightsoninfectiousdiseases
AT gobeaunathalie settingoursightsoninfectiousdiseases
AT herrmannjennifer settingoursightsoninfectiousdiseases
AT herrlingpaul settingoursightsoninfectiousdiseases
AT hopewilliam settingoursightsoninfectiousdiseases
AT keiserjennifer settingoursightsoninfectiousdiseases
AT lafuentemonasteriomariajose settingoursightsoninfectiousdiseases
AT leesonpauld settingoursightsoninfectiousdiseases
AT leroydidier settingoursightsoninfectiousdiseases
AT manjunathaujjinih settingoursightsoninfectiousdiseases
AT mccarthyjames settingoursightsoninfectiousdiseases
AT milestimothyj settingoursightsoninfectiousdiseases
AT mizrahivalerie settingoursightsoninfectiousdiseases
AT moshynetsolena settingoursightsoninfectiousdiseases
AT nilesjacquin settingoursightsoninfectiousdiseases
AT overingtonjohnp settingoursightsoninfectiousdiseases
AT pottagejohn settingoursightsoninfectiousdiseases
AT raosrinivasaps settingoursightsoninfectiousdiseases
AT readkevind settingoursightsoninfectiousdiseases
AT ribeiroisabela settingoursightsoninfectiousdiseases
AT silverlynnl settingoursightsoninfectiousdiseases
AT southernjen settingoursightsoninfectiousdiseases
AT spangenbergthomas settingoursightsoninfectiousdiseases
AT sundarshyam settingoursightsoninfectiousdiseases
AT taylorcaitlin settingoursightsoninfectiousdiseases
AT vanvoorhiswes settingoursightsoninfectiousdiseases
AT whitenicholasj settingoursightsoninfectiousdiseases
AT wylliesusan settingoursightsoninfectiousdiseases
AT wyattpaulg settingoursightsoninfectiousdiseases
AT gilbertianh settingoursightsoninfectiousdiseases